Research reveals extraordinary rates of rare neuromuscular disorder in Indigenous people in Saskatchewan

The research findings, published in the journal Neurology Genetics, revealed that among people of Indigenous descent in Saskatchewan the rate of Kennedy’s Disease is 14.7/100,000, compared with the average rate of one to two per 100,000. Of the participants in the study in the Prairie provinces, 83 per cent self-identified as Indigenous.  

“Several of us who have practices in neuromuscular disease in the Prairie provinces and Ontario have suspected that there is a much higher prevalence in our Indigenous population,” said researcher Dr. Kerri Schellenberg (MD), associate professor of neurology at USask and the medical director of the ALS Clinic at Saskatoon’s City Hospital. However, this had not previously been recognized or discussed in the medical literature, and the significance of this observation was unknown. 

Kennedy’s Disease is a hereditary disease that affects motor neurons that exit the brain stem and spinal cord into muscles of face, throat, arms, legs, and lungs. It causes weakness, cramps, muscle twitches in arms and legs, and affects speaking, swallowing, and breathing.  

The disease is known to have a higher prevalence in certain global populations due to genetic founder effects. A founder effect occurs when a genetic mutation is present within a relatively small population. Over time the mutation can become prevalent as the population grows and affected individuals with the disease share the common ancestor(s).  

Schellenberg collaborated with neurologist Dr. Gerald Pfeffer (MD), from the University of Calgary, to do further genetic analysis of patients with the disease. Work by his research team revealed that there are shared genetic markers around the mutation in most of the patients, which shows that the high prevalence is due to a founder effect. His team estimated that the founder lived approximately 250 years ago.  

Most people with Kennedy’s Disease in this study identify as Cree and Saulteaux, though not all the people who identified as Indigenous were able to identify their ancestral nations.  

When Schellenberg and Pfeffer realized how high the percent of Indigenous patients with the disease was, they reached out to Dr. Alexandra King (MD) and Dr. Malcolm King (PhD), two Indigenous faculty members of USask’s College of Medicine who head pewaseskwan Indigenous Wellness Research Group.  

The Kings, with support from pewaseskwan staff, guided them on how to engage in a culturally safe manner with the patients. They helped by creating a Community Guiding Circle and assisted with meeting during which the research findings were shared with the participants.  

“Before we presented the information to anybody else, we had a meeting with the participants of that research study. We presented it and then we sat down and listened. It became clear that this was of strong interest to people, and they wanted to see the project move forward,” Schellenberg said. 

The patients want to better understand the disease and its high prevalence in their communities and get better resources and awareness. They also expressed interested in having the researchers connect with Elders, Knowledge Holders and community leaders to discuss the findings.  

The research team has received a $50,000 grant from the Kennedy’s Disease Association to continue this research. They will expand the work to Edmonton, Calgary, Winnipeg, Thunder Bay, Ont., and do more research with patients in Saskatoon. As they recruit participants in the new sites, they will also expand the Community Guiding Circle to include patients from those places. The Kings and pewaseskwan will continue to support the research. 

This research study has been published as an open-access article and is available at: https://ng.neurology.org/content/7/4/e607